SOSTDC1 antibody (N-Term)
Quick Overview for SOSTDC1 antibody (N-Term) (ABIN207358)
Target
See all SOSTDC1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Synthetic peptide corresponding to N-terminal residues of human SOSTDC1 (Sclerostin domain containing protein 1)
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from human SOSTDC1.
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
- Approved: ELISA (1 μg/mL), WB (1 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.01 % sodium azide, 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- avoid freeze thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles.
-
-
- SOSTDC1 (Sclerostin Domain Containing 1 (SOSTDC1))
-
Alternative Name
- USAG1 / SOSTDC1
-
Background
-
Name/Gene ID: SOSTDC1
Synonyms: SOSTDC1, CDA019, Ectodermal BMP inhibitor, USAG1, USAG-1, ECTODIN, Sclerostin domain containing 1 -
Gene ID
- 25928
-
UniProt
- Q6X4U4
Target
-